Simulations Plus, Inc. (NASDAQ:SLP) Receives $50.00 Consensus PT from Brokerages

Shares of Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) have earned an average rating of "Buy" from the seven research firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $50.00.

SLP has been the topic of a number of recent research reports. StockNews.com cut shares of Simulations Plus from a "hold" rating to a "sell" rating in a research note on Monday, April 14th. KeyCorp increased their price objective on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday. Finally, William Blair reissued an "outperform" rating on shares of Simulations Plus in a report on Wednesday, January 8th.

Insider Activity at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the sale, the director now owns 3,402,584 shares in the company, valued at $115,381,623.44. This trade represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 19.40% of the stock is currently owned by insiders.

Institutional Trading of Simulations Plus

A number of hedge funds have recently bought and sold shares of the company. Fifth Third Bancorp grew its position in Simulations Plus by 33.8% during the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock worth $36,000 after acquiring an additional 375 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Simulations Plus by 4.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,103 shares of the technology company's stock worth $254,000 after acquiring an additional 380 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Simulations Plus by 53.6% during the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after purchasing an additional 427 shares during the last quarter. Pitcairn Co. raised its stake in Simulations Plus by 10.8% during the fourth quarter. Pitcairn Co. now owns 7,310 shares of the technology company's stock valued at $204,000 after buying an additional 711 shares during the last quarter. Finally, US Bancorp DE boosted its stake in Simulations Plus by 14.3% in the 4th quarter. US Bancorp DE now owns 5,687 shares of the technology company's stock worth $159,000 after purchasing an additional 713 shares in the last quarter. Institutional investors own 78.08% of the company's stock.

Simulations Plus Stock Performance

SLP stock traded up $0.49 during mid-day trading on Thursday, hitting $32.69. The company had a trading volume of 336,728 shares, compared to its average volume of 193,468. Simulations Plus has a 12 month low of $23.01 and a 12 month high of $51.22. The stock's fifty day moving average price is $28.55 and its two-hundred day moving average price is $30.09. The firm has a market cap of $657.43 million, a PE ratio of 81.73 and a beta of 1.13.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The business had revenue of $22.43 million during the quarter, compared to the consensus estimate of $21.93 million. During the same period last year, the business posted $0.20 earnings per share. The business's revenue for the quarter was up 22.5% on a year-over-year basis. Equities analysts anticipate that Simulations Plus will post 1.09 earnings per share for the current year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.